FR941011-2-00139 FR941011-2-00089 Self-Regulatory Organizations; Applications for Unlisted Trading Privileges; Notice and Opportunity for Hearing; Philadelphia Stock Exchange, Inc. October 4, 1994. The above named national securities exchange has filed applications with the Securities and Exchange Commission (``Commission'') pursuant to Section 12(f)(1)(B) of the Securities Exchange Act of 1934 and Rule 12f&hyph;1 thereunder for unlisted trading privileges in the following securities: Templeton Dragon Fund, Inc. Common Stock, $.01 Par Value (File No. 7&hyph;13000) Biovail Corporation Common Stock, No Par Value (File No. 7&hyph;13001) Medquist, Inc. Common Stock, No Par Value (File No. 7&hyph;13002) Templeton Vietnam Opportunities Fund, Inc. Common Stock, $.01 Par Value (File No. 7&hyph;13003) Czech Republic Fund, Inc. Common Stock, $.001 Par Value (File No. 7&hyph;13004) Sterile Concepts Holdings, Inc. Common Stock, No Par Value (File No. 7&hyph;13005) These securities are listed and registered on one or more other national securities exchanges and are reported in the consolidated transaction reporting system. Interested persons are invited to submit on or before October 26, 1994, written data, views and arguments concerning the above-referenced application. Persons desiring to make written comments should file three copies thereof with the Secretary of the Securities and Exchange Commission, 450 5th Street NW., Washington, DC 20549. Following this opportunity for hearing, the Commission will approve the application if it finds, based upon all the information available to it, that the extensions of unlisted trading privileges pursuant to such applications are consistent with the maintenance of fair and orderly markets and the protection of investors. For the Commission, by the Division of Market Regulation, pursuant to delegated authority. Jonathan G. Katz, Secretary. [FR Doc. 94&hyph;25044 Filed 10&hyph;7&hyph;94; 8:45 am] BILLING CODE 8010&hyph;01&hyph;M
